Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $98 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel has reiterated a Buy rating on Dolby Laboratories (NYSE:DLB) and maintained a price target of $98.
November 17, 2023 | 1:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel reiterates a Buy rating on Dolby Laboratories with a maintained price target of $98.
The reiteration of a Buy rating by a prominent analyst like Steve Frankel from Rosenblatt, along with the maintenance of a $98 price target, is a positive endorsement for Dolby Laboratories. This could lead to increased investor confidence and a potential short-term uplift in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100